-The Times of India MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...

-The Times of India Funding for one of the foremost drug discovery projects in India came to an end on Monday as the financial year closed because the ministry of science and technology did not clear the cabinet note meant to extend funding for the project on time. The Open Source Drug Discovery (OSDD) project of the Council of Scientific and Industrial Research (CSIR), meant to discover drugs for neglected diseases, had...

-The Economic Times Anshu Prakash is worried about what he calls "mischievous propaganda" by "some people" who he thinks are misleading reporters. The joint secretary at the ministry of health and family welfare starts off by flatly denying that the joint monitoring mission (JMM) set up by the World Health Organization (WHO) and the government of India (GoI) discussed the impending danger of a TB drugs stock-out in August 2012. "There was...

-The Hindu   "The court has recognised the right of patients to access affordable medicines over profits for big pharma companies" It was celebration time for health activists and civil society groups after the Supreme Court delivered its judgment dismissing Swiss multinational company Novartis' appeal for patent for its anti-cancer medicine imatinib mesylate or Gleevec. "We are happy that the apex court has recognised the right of patients to access affordable medicines over profits...

-The Economic Times Over the past 15 months, rural development minister Jairam Ramesh has made more than 150 visits to 41 of the 82 Naxal-affected districts. Emerging as the government's face in these remote areas, Ramesh talks to ET about the efforts and progress needed to contain the Maoist influence. * Fifteen months of "development" focus in the Naxal-affected areas. What's the progress? It's a mixed bag: some progress in Jharkhand, West...